|
|
|
Size
|
Re: LDL and mortality (and use of statins)
|
Owen Dempsey |
Thu, 1 Nov 2018 11:28:16 +0000 |
1984 lines |
New Postgraduate Certificate in Teaching Evidence-Based Health Care
|
University of Oxford CPD Centre |
Thu, 1 Nov 2018 12:00:21 +0000 |
609 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Thu, 1 Nov 2018 14:41:50 +0000 |
1760 lines |
Screening.
|
Glen Burgoyne |
Thu, 1 Nov 2018 15:01:57 +0000 |
49 lines |
Re: LDL and mortality (and use of statins)
|
Evelyn Cornelissen |
Thu, 1 Nov 2018 08:47:28 -0700 |
2280 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Thu, 1 Nov 2018 16:45:48 +0000 |
1787 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Thu, 1 Nov 2018 17:00:16 +0000 |
1607 lines |
Re: LDL and mortality (and use of statins)
|
Djulbegovic, Benjamin |
Thu, 1 Nov 2018 17:27:47 +0000 |
1750 lines |
Re: LDL and mortality (and use of statins)
|
Juan Gérvas |
Thu, 1 Nov 2018 18:47:45 +0100 |
2890 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Thu, 1 Nov 2018 20:14:00 +0000 |
1905 lines |
Re: LDL and mortality (and use of statins)
|
Juan Gérvas |
Thu, 1 Nov 2018 22:01:33 +0100 |
3209 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Thu, 1 Nov 2018 21:09:06 +0000 |
2235 lines |
Re: LDL and mortality (and use of statins)
|
Owen Dempsey |
Thu, 1 Nov 2018 21:10:49 +0000 |
2917 lines |
Re: LDL and mortality (and use of statins)
|
Juan Gérvas |
Thu, 1 Nov 2018 22:20:08 +0100 |
3008 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Thu, 1 Nov 2018 21:21:32 +0000 |
1997 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Thu, 1 Nov 2018 21:34:45 +0000 |
2107 lines |
Re: LDL and mortality (and use of statins)
|
Juan Gérvas |
Thu, 1 Nov 2018 22:47:40 +0100 |
3206 lines |
Re: LDL and mortality (and use of statins)
|
Neal Maskrey |
Thu, 1 Nov 2018 17:57:17 -0400 |
3210 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Thu, 1 Nov 2018 22:32:26 +0000 |
2599 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Thu, 1 Nov 2018 22:59:21 +0000 |
2203 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Thu, 1 Nov 2018 19:05:27 -0400 |
3384 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Thu, 1 Nov 2018 23:15:46 +0000 |
2283 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Thu, 1 Nov 2018 23:19:33 +0000 |
2883 lines |
Re: LDL and mortality (and use of statins)
|
Lyndal Trevena |
Thu, 1 Nov 2018 23:23:21 +0000 |
2764 lines |
Re: LDL and mortality (and use of statins)
|
Djulbegovic, Benjamin |
Thu, 1 Nov 2018 23:30:27 +0000 |
2529 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Thu, 1 Nov 2018 19:32:37 -0400 |
3516 lines |
Re: LDL and mortality (and use of statins)
|
Neal Maskrey |
Thu, 1 Nov 2018 20:24:29 -0400 |
3308 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Fri, 2 Nov 2018 00:53:40 +0000 |
3293 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Thu, 1 Nov 2018 21:07:18 -0400 |
4388 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Fri, 2 Nov 2018 02:15:50 +0000 |
3046 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Thu, 1 Nov 2018 22:23:09 -0400 |
5101 lines |
Re: LDL and mortality (and use of statins)
|
Neal Maskrey |
Thu, 1 Nov 2018 23:14:44 -0400 |
4686 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Fri, 2 Nov 2018 04:22:55 +0000 |
3913 lines |
Re: LDL and mortality (and use of statins)
|
Michael Power |
Fri, 2 Nov 2018 06:06:31 +0000 |
5570 lines |
Re: LDL and mortality (and use of statins)
|
Owen Dempsey |
Fri, 2 Nov 2018 11:41:32 +0000 |
5895 lines |
Please read apropos recent discussion of screening
|
Donald E. Stanley |
Fri, 2 Nov 2018 15:05:08 +0000 |
30 lines |
Re: LDL and mortality (and use of statins)
|
Djulbegovic, Benjamin |
Fri, 2 Nov 2018 15:31:37 +0000 |
5933 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Fri, 2 Nov 2018 15:40:16 +0000 |
4304 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Fri, 2 Nov 2018 15:49:16 +0000 |
4389 lines |
New website for Teachers of EBHC
|
Douglas Badenoch |
Fri, 2 Nov 2018 15:52:53 +0000 |
142 lines |
Re: LDL and mortality (and use of statins)
|
Juan Gérvas |
Fri, 2 Nov 2018 17:49:45 +0100 |
6372 lines |
Re: LDL and mortality (and use of statins)
|
Huw Llewelyn [hul2] |
Fri, 2 Nov 2018 16:49:56 +0000 |
4466 lines |
Re: LDL and mortality (and use of statins)
|
Djulbegovic, Benjamin |
Fri, 2 Nov 2018 17:42:53 +0000 |
3580 lines |
Re: LDL and mortality (and use of statins)
|
Owen Dempsey |
Fri, 2 Nov 2018 21:34:33 +0000 |
6312 lines |
Re: LDL and mortality (and use of statins)
|
Djulbegovic, Benjamin |
Sat, 3 Nov 2018 01:01:10 +0000 |
6127 lines |
Re: LDL and mortality (and use of statins)
|
Neal Maskrey |
Fri, 2 Nov 2018 21:29:37 -0400 |
7279 lines |
Re: LDL and mortality (and use of statins)
|
Glen Burgoyne |
Sat, 3 Nov 2018 02:47:23 +0000 |
4799 lines |
Re: LDL and mortality (and use of statins)
|
Kumara Mendis |
Sat, 3 Nov 2018 10:17:48 +0530 |
7103 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Sat, 3 Nov 2018 07:04:25 +0000 |
1219 lines |
Re: EBM or GFBM "GutFeelingBasedMedicine"?
|
Wouter Havinga |
Sat, 3 Nov 2018 08:04:29 +0000 |
94 lines |
Re: LDL and mortality (and use of statins)
|
Vasiliy Vlassov |
Sat, 3 Nov 2018 13:15:43 +0300 |
68 lines |
Re: LDL and mortality (and use of statins)
|
Per Olav Vandvik |
Sat, 3 Nov 2018 11:28:54 +0100 |
6562 lines |
Re: LDL and mortality (and use of statins)
|
Owen Dempsey |
Sat, 3 Nov 2018 11:35:02 +0000 |
7391 lines |
Re: LDL and mortality (and use of statins)
|
Vasiliy Vlassov |
Sat, 3 Nov 2018 15:34:39 +0300 |
87 lines |
Re: EBM or GFBM "GutFeelingBasedMedicine"?
|
David Richard Leslie Cawthorpe |
Sat, 3 Nov 2018 15:14:23 +0000 |
332 lines |
Should testing of asymptomatic patients and screening be abandoned?
|
Djulbegovic, Benjamin |
Sat, 3 Nov 2018 18:02:56 +0000 |
146 lines |
Re: LDL and mortality (and use of statins)
|
Owen Dempsey |
Sat, 3 Nov 2018 21:08:45 +0000 |
301 lines |
Re: Should testing of asymptomatic patients and screening be abandoned?
|
Rod Jackson |
Sat, 3 Nov 2018 21:19:01 +0000 |
141 lines |
Re: Should testing of asymptomatic patients and screening be abandoned?
|
Owen Dempsey |
Sat, 3 Nov 2018 21:34:33 +0000 |
444 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Sat, 3 Nov 2018 17:55:47 -0400 |
2132 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Sat, 3 Nov 2018 22:36:48 +0000 |
1470 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Sat, 3 Nov 2018 19:02:23 -0400 |
2285 lines |
Re: LDL and mortality (and use of statins)
|
McCormack, James |
Sat, 3 Nov 2018 23:30:50 +0000 |
1597 lines |
Re: LDL and mortality (and use of statins)
|
Kumara Mendis |
Sun, 4 Nov 2018 06:36:58 +0530 |
2553 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Sat, 3 Nov 2018 23:55:19 -0400 |
2469 lines |
Urgent 24 hours: Please sign this letter to the Danish Minister of Health against the dismissal of Peter Gotzsche from his job at Rigshospitalet in Copenhagen
|
Juan Gérvas |
Sun, 4 Nov 2018 18:34:14 +0100 |
257 lines |
Re: LDL and mortality (and use of statins)
|
Rod Jackson |
Sun, 4 Nov 2018 20:04:36 +0000 |
1425 lines |
Re: Should testing of asymptomatic patients and screening be abandoned?
|
Rod Jackson |
Sun, 4 Nov 2018 20:09:10 +0000 |
136 lines |
Re: Urgent 24 hours: Please sign this letter to the Danish Minister of Health against the dismissal of Peter Gotzsche from his job at Rigshospitalet in Copenhagen
|
Juan Gérvas |
Sun, 4 Nov 2018 22:41:59 +0100 |
367 lines |
Re: LDL and mortality (and use of statins)
|
Mohammed T. Ansari |
Sun, 4 Nov 2018 17:43:41 -0500 |
2451 lines |
Primary care risk prevention in a nutshell
|
McCormack, James |
Mon, 5 Nov 2018 02:04:59 +0000 |
49 lines |
Re: Primary care risk prevention in a nutshell
|
Michael Power |
Mon, 5 Nov 2018 08:09:09 +0000 |
221 lines |
Re: Should testing of asymptomatic patients and screening be abandoned?
|
Kelleher, Kevin |
Mon, 5 Nov 2018 09:21:36 +0000 |
178 lines |
Re: Primary care risk prevention in a nutshell
|
Owen Dempsey |
Mon, 5 Nov 2018 13:07:05 +0000 |
270 lines |
Re: Primary care risk prevention in a nutshell
|
McCormack, James |
Mon, 5 Nov 2018 15:25:18 +0000 |
223 lines |
Re: Primary care risk prevention in a nutshell
|
McCormack, James |
Mon, 5 Nov 2018 15:39:55 +0000 |
374 lines |
Reduced Salt Intake for Heart Failure A Systematic Review
|
David Nunan |
Mon, 5 Nov 2018 16:18:43 +0000 |
207 lines |
Re: Reduced Salt Intake for Heart Failure A Systematic Review
|
Rakesh Biswas |
Tue, 6 Nov 2018 09:03:51 +0530 |
272 lines |
Diversity in academy, and leadership
|
Juan Gérvas |
Tue, 6 Nov 2018 11:09:03 +0100 |
418 lines |
How to conduct a high-quality original study on a prognostic research topic
|
Yao, Xiaomei |
Tue, 6 Nov 2018 18:43:10 +0000 |
343 lines |
Bye Bye Peter Gøtzsche. We need another Cochrane
|
Juan Gérvas |
Tue, 6 Nov 2018 22:17:46 +0100 |
56 lines |
Re: How to conduct a high-quality original study on a prognostic research topic
|
Rod Jackson |
Wed, 7 Nov 2018 01:50:18 +0000 |
391 lines |
Re: How to conduct a high-quality original study on a prognostic research topic
|
Yao, Xiaomei |
Wed, 7 Nov 2018 05:12:17 +0000 |
473 lines |
Tutorial for Reproducible Search and Session on Automation of Systematic Reviews
|
Farhad Shokraneh |
Wed, 7 Nov 2018 16:09:40 +0000 |
219 lines |
Re: Primary care risk prevention in a nutshell
|
Owen Dempsey |
Wed, 7 Nov 2018 17:13:49 +0000 |
713 lines |
Re: Primary care risk prevention in a nutshell
|
Djulbegovic, Benjamin |
Wed, 7 Nov 2018 17:42:31 +0000 |
775 lines |
Re: Primary care risk prevention in a nutshell
|
Jim Walker |
Wed, 7 Nov 2018 13:25:15 -0500 |
1173 lines |
Re: Primary care risk prevention in a nutshell
|
Amy Price |
Wed, 7 Nov 2018 18:52:20 +0000 |
900 lines |
Re: Primary care risk prevention in a nutshell
|
Rod Jackson |
Wed, 7 Nov 2018 19:26:04 +0000 |
938 lines |
Re: Primary care risk prevention in a nutshell
|
McCormack, James |
Wed, 7 Nov 2018 20:03:46 +0000 |
1375 lines |
Re: Primary care risk prevention in a nutshell
|
Ash Paul |
Wed, 7 Nov 2018 20:09:45 +0000 |
1459 lines |
Re: Primary care risk prevention in a nutshell
|
[log in to unmask] |
Wed, 7 Nov 2018 20:26:06 +0000 |
1635 lines |
Re: Primary care risk prevention in a nutshell
|
Amy Price |
Wed, 7 Nov 2018 20:40:57 +0000 |
1121 lines |
Re: Primary care risk prevention in a nutshell
|
Amy Price |
Wed, 7 Nov 2018 20:44:45 +0000 |
1167 lines |
Re: Primary care risk prevention in a nutshell
|
Neal Maskrey |
Wed, 7 Nov 2018 17:30:47 -0400 |
1855 lines |
Business Analytics and AI workshops live and online
|
Geoffrey Hubona |
Thu, 8 Nov 2018 09:58:27 -0700 |
28 lines |
Name that study! Do we need a new category?
|
Kev Hopayian |
Fri, 9 Nov 2018 09:24:58 +0000 |
1199 lines |
Job vacancy in Abersdeen
|
BROWN, Juliet (NHS HEALTHCARE IMPROVEMENT SCOTLAND) |
Fri, 9 Nov 2018 09:44:54 +0000 |
79 lines |
Job vacancy - Lead Health Services Researcher
|
Karen Macpherson |
Fri, 9 Nov 2018 15:51:28 +0000 |
67 lines |
Re: BMJ News reporting 14% increased risk of ACEI associated lung cancer
|
Yao, Xiaomei |
Fri, 9 Nov 2018 17:37:51 +0000 |
635 lines |
Re: Name that study! Do we need a new category?
|
Dan Mayer |
Fri, 9 Nov 2018 16:17:30 -0500 |
264 lines |
Re: Name that study! Do we need a new category?
|
Birnbaum, David |
Fri, 9 Nov 2018 22:07:11 +0000 |
302 lines |
Re: Name that study! Do we need a new category?
|
Michael Power |
Fri, 9 Nov 2018 22:33:22 +0000 |
1236 lines |
Re: Name that study! Do we need a new category?
|
Pennington, Andy |
Fri, 9 Nov 2018 23:58:20 +0000 |
882 lines |
Crisis Cochrane. Peter C Gøtzsche's voice
|
Juan Gérvas |
Sat, 10 Nov 2018 16:01:45 +0100 |
54 lines |
Re: Name that study! Do we need a new category?
|
Rod Jackson |
Sat, 10 Nov 2018 20:37:52 +0000 |
915 lines |
Re: Primary care risk prevention in a nutshell
|
Owen Dempsey |
Sat, 10 Nov 2018 22:02:22 +0000 |
2056 lines |
Re: How a medical student can learn critical appraisal skills when medical school don't teach??
|
avinash kumar gupta |
Sun, 11 Nov 2018 11:09:50 +0545 |
1841 lines |
Re: Name that study! Do we need a new category?
|
Kev Hopayian |
Sun, 11 Nov 2018 09:43:44 +0000 |
354 lines |
Re: Name that study! Do we need a new category?
|
Kev Hopayian |
Sun, 11 Nov 2018 09:57:53 +0000 |
334 lines |
Difference in difference estimation
|
Kev Hopayian |
Sun, 11 Nov 2018 11:03:43 +0000 |
193 lines |
Re: Difference in difference estimation
|
Pennington, Andy |
Sun, 11 Nov 2018 16:15:51 +0000 |
221 lines |
examples of ethical censoring
|
Vasiliy Vlassov |
Sun, 11 Nov 2018 21:02:08 +0300 |
34 lines |
Re: Name that study! Do we need a new category?
|
Dan Mayer |
Sun, 11 Nov 2018 13:44:24 -0500 |
329 lines |
Re: Name that study! Do we need a new category?
|
Federico Barbani USL |
Sun, 11 Nov 2018 19:50:33 +0100 |
263 lines |
Re: Name that study! Do we need a new category?
|
Djulbegovic, Benjamin |
Sun, 11 Nov 2018 19:32:23 +0000 |
534 lines |
Re: Name that study! Do we need a new category?
|
Federico Barbani |
Sun, 11 Nov 2018 22:31:02 +0100 |
656 lines |
Re: How a medical student can learn critical appraisal skills when medical school don't teach??
|
Rod Jackson |
Mon, 12 Nov 2018 03:34:19 +0000 |
1343 lines |
Re: Name that study! Do we need a new category?
|
Kev Hopayian |
Mon, 12 Nov 2018 10:48:16 +0000 |
789 lines |
Re: Name that study! Do we need a new category?
|
Kev Hopayian |
Mon, 12 Nov 2018 11:40:12 +0000 |
425 lines |
Why is the fatality rate so low?
|
Guylene Theriault |
Mon, 12 Nov 2018 12:58:19 +0000 |
149 lines |
Re: Name that study! Do we need a new category?
|
[log in to unmask] |
Mon, 12 Nov 2018 14:01:15 +0000 |
600 lines |
Re: Name that study! Do we need a new category?
|
Djulbegovic, Benjamin |
Mon, 12 Nov 2018 14:39:27 +0000 |
855 lines |
Re: examples of ethical censoring
|
Djulbegovic, Benjamin |
Mon, 12 Nov 2018 15:07:57 +0000 |
80 lines |
How Cochrane is doing pharma a good turn
|
Tom Jefferson |
Mon, 12 Nov 2018 16:16:36 +0100 |
99 lines |
Re: Name that study! Do we need a new category?
|
Michael Power |
Mon, 12 Nov 2018 16:34:05 +0000 |
1130 lines |
Re: Name that study! Do we need a new category?
|
David Nunan |
Mon, 12 Nov 2018 16:57:24 +0000 |
763 lines |
Re: Name that study! Do we need a new category?
|
Janet Martin |
Mon, 12 Nov 2018 17:13:54 +0000 |
864 lines |
Re: Name that study! Do we need a new category?
|
Dr. Abdelhamid Attia |
Mon, 12 Nov 2018 20:06:39 +0200 |
365 lines |
Re: How Cochrane is doing pharma a good turn
|
Juan Gérvas |
Mon, 12 Nov 2018 22:53:20 +0100 |
180 lines |
REMINDER: Mixed Methods Systematic Review and Searching the Evidence Base Courses - Early bird rate closing soon!
|
Judy Wright |
Tue, 13 Nov 2018 11:05:15 +0000 |
379 lines |
Re: Name that study! Do we need a new category?
|
Kev Hopayian |
Tue, 13 Nov 2018 17:13:38 +0000 |
403 lines |
Re: Name that study! Do we need a new category?
|
Kev Hopayian |
Tue, 13 Nov 2018 17:43:20 +0000 |
1011 lines |
Re: Name that study! Do we need a new category?
|
Djulbegovic, Benjamin |
Tue, 13 Nov 2018 20:34:43 +0000 |
1015 lines |
Re: How a medical student can learn critical appraisal skills when medical school don't teach??
|
Chris Del Mar |
Wed, 14 Nov 2018 06:19:36 +0000 |
1717 lines |
Real-World Evidence is here to stay
|
Ernesto Barrera |
Thu, 15 Nov 2018 09:58:47 +0100 |
73 lines |
Introduction to Statistics for Health Care Research, University of Oxford
|
University of Oxford CPD Centre |
Thu, 15 Nov 2018 11:44:50 +0000 |
1107 lines |
Cochrane Crisis. John Ioannidis
|
Juan Gérvas |
Sun, 18 Nov 2018 13:44:04 +0100 |
211 lines |
Re: Cochrane Crisis. John Ioannidis
|
Juan Gérvas |
Sun, 18 Nov 2018 14:09:44 +0100 |
250 lines |
Re: Cochrane Crisis. John Ioannidis
|
Juan Gérvas |
Tue, 20 Nov 2018 08:55:01 +0100 |
305 lines |
Job Vacancy - Band 6 - Clinical Librarian
|
WILLIAMS, Christine (DARTFORD AND GRAVESHAM NHS TRUST) |
Thu, 22 Nov 2018 14:29:09 +0000 |
456 lines |
Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?
|
Rod Jackson |
Sat, 24 Nov 2018 02:31:36 +0000 |
57 lines |
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?
|
Jim Mann |
Sat, 24 Nov 2018 03:37:45 +0000 |
98 lines |
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?
|
Carl Heneghan |
Sat, 24 Nov 2018 11:54:57 +0000 |
84 lines |
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?
|
David Nunan |
Sat, 24 Nov 2018 15:03:01 +0000 |
82 lines |
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?
|
McCormack, James |
Sat, 24 Nov 2018 18:02:10 +0000 |
113 lines |
Re: Please help me develop a collective critique of the latest PURE study results which we can publish in BMJ EBM
|
Rod Jackson |
Sat, 24 Nov 2018 21:31:15 +0000 |
284 lines |
Medical devices. #implantfiles
|
Juan Gérvas |
Sun, 25 Nov 2018 18:28:50 +0100 |
83 lines |
Re: Medical devices. #implantfiles
|
Juan Gérvas |
Sun, 25 Nov 2018 23:14:03 +0100 |
112 lines |
Early Bird Final REMINDER: Mixed Methods Systematic Review and Searching the Evidence Base Courses
|
Judy Wright |
Mon, 26 Nov 2018 15:37:11 +0000 |
380 lines |
Job Vacancy - Information Specialist, Leeds Institute of Health Sciences, University of Leeds
|
Judy Wright |
Thu, 29 Nov 2018 14:13:04 +0000 |
205 lines |